Inhibition of Aggregation of Amyloid β42 by Arginine-Containing Small Compounds
Authors:
- Takayasu KawasakiTKTakayasu Kawasaki
- Shunsuke KamijoSKShunsuke Kamijo
- 23 April 2012
- journal article
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 76 (4) , 762-766
Abstract
Aggregations of proteins are in many cases associated with neurodegenerative diseases such as Alzheimer's (AD). Small compounds capable of inhibiting protein aggregation are expected to be useful for not only in the treatment of disease but also in probing the structures of aggregated proteins. In previous studies using phage display, we found that arginine-rich short peptides consisting of four or seven amino acids bound to soluble 42-residue amyloid β (Aβ42) and inhibited globulomer (37/48 kDa oligomer) formation. In the present study, we searched for arginine-containing small molecules using the SciFinder searching service and tested their inhibitory activities against Aβ42 aggregation, by sodium dodecyl sulfate (SDS)-PAGE and thioflavine T binding assay. Commercially available Arg-Arg-7-amino-4-trifluoromethylcoumarin was found to exhibit remarkable inhibitory activities to the formation of the globulomer and the fibril of Aβ42. This chimera-type tri-peptide is expected to serve as the seed molecule of a potent inhibitor of the Aβ aggregation process.Keywords
This publication has 18 references indexed in Scilit:
- Identification of Novel Short Peptide Inhibitors of Soluble 37/48 kDa Oligomers of Amyloid β42Bioscience, Biotechnology, and Biochemistry, 2011
- Selection of Peptide Inhibitors of Soluble Aβ1-42Oligomer Formation by Phage DisplayBioscience, Biotechnology, and Biochemistry, 2010
- Polymorphic C-terminal β-Sheet Interactions Determine the Formation of Fibril or Amyloid β-derived Diffusible Ligand-like Globulomer for the Alzheimer Aβ42 DodecamerJournal of Biological Chemistry, 2010
- Generation and Therapeutic Efficacy of Highly Oligomer-Specific β-Amyloid AntibodiesJournal of Neuroscience, 2010
- Amyloid oligomers: formation and toxicity of Aβ oligomersThe FEBS Journal, 2010
- Computational selection of inhibitors of Aβ aggregation and neuronal toxicityBioorganic & Medicinal Chemistry, 2009
- The chemistry of Alzheimer’s diseaseChemical Society Reviews, 2009
- Structural Characterization of a Soluble Amyloid β-Peptide OligomerBiochemistry, 2009
- Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's diseaseJournal of Neurochemistry, 2005
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature Cell Biology, 2004